Gonadotrophins for idiopathic male factor subfertility
- PMID: 17943837
- DOI: 10.1002/14651858.CD005071.pub3
Gonadotrophins for idiopathic male factor subfertility
Update in
-
Gonadotrophins for idiopathic male factor subfertility.Cochrane Database Syst Rev. 2013 Aug 23;2013(8):CD005071. doi: 10.1002/14651858.CD005071.pub4. Cochrane Database Syst Rev. 2013. PMID: 23970458 Free PMC article. Review.
Abstract
Background: Male factor infertility accounts for 50% of all infertility. The treatment of idiopathic male infertility is empirical. Urinary, purified, and recombinant gonadotrophins have been used to improve sperm parameters in idiopathic male infertility with the goal of increasing pregnancy rates. Research addressing pregnancy rates in partners of men treated with gonadotrophins has had conflicting results and needs to be analysed.
Objectives: To determine the effectiveness of gonadotrophin administration in men with idiopathic subfertility in improving spontaneous pregnancy rate and in assisted reproductive technique cycles.
Search strategy: We searched the Cochrane Menstrual Disorders and Subfertility Group trials register (31 May 2007), the Cochrane Central Register of Controlled Trials (The Cochrane Library, issue 2, 2007), MEDLINE (1966 to May 2007), EMBASE and Biological Abstracts (1980 to Week 21 2007). Searches were not limited by language. The bibliographies of included, excluded trials and abstracts of major meetings were searched for additional trials. Authors and pharmaceutical companies were contacted for missing and unpublished data.
Selection criteria: Truly randomised controlled trials where gonadotrophins were administered for the treatment of idiopathic male subfertility with reporting of pregnancy rates were included in the review.
Data collection and analysis: Two reviewers independently assessed trial quality and extracted data. Study authors were contacted for additional information. Adverse effects information was collected from the trials. We analysed data regarding pregnancy occurring within three months after gonadotrophin therapy.
Main results: Four RCTs with 278 participants were included in the analysis. None of the studies had an adequate sample size and they had variable follow-up periods. None of the studies reported live birth or miscarriage rates. Compared to placebo or no treatment, gonadotrophins showed a significantly higher pregnancy rate per couple randomized within three months of completing therapy ( OR 4.17, 95% CI 1.30 to 7.09).
Authors' conclusions: The number of trials and participants is insufficient to draw final conclusions. A large multicenter study with adequate power is needed.
Update of
-
Gonadotrophins for idiopathic male factor subfertility.Cochrane Database Syst Rev. 2006 Jan 25;(1):CD005071. doi: 10.1002/14651858.CD005071.pub2. Cochrane Database Syst Rev. 2006. Update in: Cochrane Database Syst Rev. 2007 Oct 17;(4):CD005071. doi: 10.1002/14651858.CD005071.pub3 PMID: 16437514 Updated. Review.
Similar articles
-
Gonadotrophins for idiopathic male factor subfertility.Cochrane Database Syst Rev. 2006 Jan 25;(1):CD005071. doi: 10.1002/14651858.CD005071.pub2. Cochrane Database Syst Rev. 2006. Update in: Cochrane Database Syst Rev. 2007 Oct 17;(4):CD005071. doi: 10.1002/14651858.CD005071.pub3 PMID: 16437514 Updated. Review.
-
Gonadotrophins for idiopathic male factor subfertility.Cochrane Database Syst Rev. 2013 Aug 23;2013(8):CD005071. doi: 10.1002/14651858.CD005071.pub4. Cochrane Database Syst Rev. 2013. PMID: 23970458 Free PMC article. Review.
-
Antioxidants for male subfertility.Cochrane Database Syst Rev. 2014;(12):CD007411. doi: 10.1002/14651858.CD007411.pub3. Epub 2014 Dec 15. Cochrane Database Syst Rev. 2014. Update in: Cochrane Database Syst Rev. 2019 Mar 14;3:CD007411. doi: 10.1002/14651858.CD007411.pub4 PMID: 25504418 Updated. Review.
-
Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome.Cochrane Database Syst Rev. 2000;(4):CD000410. doi: 10.1002/14651858.CD000410. Cochrane Database Syst Rev. 2000. Update in: Cochrane Database Syst Rev. 2015 Aug 24;(8):CD000410. doi: 10.1002/14651858.CD000410.pub2 PMID: 11034687 Updated. Review.
-
Recombinant versus urinary human chorionic gonadotrophin for ovulation induction in assisted conception.Cochrane Database Syst Rev. 2005 Apr 18;(2):CD003719. doi: 10.1002/14651858.CD003719.pub2. Cochrane Database Syst Rev. 2005. Update in: Cochrane Database Syst Rev. 2011 Apr 13;(4):CD003719. doi: 10.1002/14651858.CD003719.pub3 PMID: 15846677 Updated. Review.
Cited by
-
FSH treatment in infertile males candidate to assisted reproduction improved sperm DNA fragmentation and pregnancy rate.Endocrine. 2017 May;56(2):416-425. doi: 10.1007/s12020-016-1037-z. Epub 2016 Jul 27. Endocrine. 2017. PMID: 27465288
-
Approach to male infertility and induction of spermatogenesis.J Clin Endocrinol Metab. 2013 Sep;98(9):3532-42. doi: 10.1210/jc.2012-2400. J Clin Endocrinol Metab. 2013. PMID: 24014811 Free PMC article. Review.
-
Effects of highly purified follicle-stimulating hormone on sperm DNA damage in men with male idiopathic subfertility: a pilot study.J Endocrinol Invest. 2011 Nov;34(10):747-52. doi: 10.3275/7745. Epub 2011 May 23. J Endocrinol Invest. 2011. PMID: 21606671
-
Testosterone Serum Levels Are Related to Sperm DNA Fragmentation Index Reduction after FSH Administration in Males with Idiopathic Infertility.Biomedicines. 2022 Oct 17;10(10):2599. doi: 10.3390/biomedicines10102599. Biomedicines. 2022. PMID: 36289860 Free PMC article.
-
Rescue in vitro fertilization using a GnRH antagonist in hyper-responders from gonadotropin intrauterine insemination (IUI) cycles.J Assist Reprod Genet. 2013 Jun;30(6):773-8. doi: 10.1007/s10815-013-0016-z. Epub 2013 May 30. J Assist Reprod Genet. 2013. PMID: 23715874 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical